Johnson & Johnson Vaccinations Paused After Rare Clotting Cases Emerge. Coronavirus (2019-nCoV), Vaccination and Immunization, Johnson & Johnson, Blood Clots, Centers for Disease Control and Prevention, Food and Drug Administration, United States Politics and Government, Regulation and Deregulation of Industry, Moderna Inc, Pfizer Inc, AstraZeneca PLC